These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8899842)

  • 21. The L6 muscle cell line as a tool to evaluate parenteral products for irritation.
    Laska DA; Williams PD; Reboulet JT; Morris RM
    J Parenter Sci Technol; 1991; 45(2):77-82. PubMed ID: 2051260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical properties of binary organic cosolvent-water mixtures and their relationships to muscle damage following intramuscular injection.
    Brazeau GA; Fung HL
    J Parenter Sci Technol; 1989; 43(4):144-9. PubMed ID: 2769521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of an in vitro haemolysis test to predict tissue irritancy in an intramuscular formulation.
    Brown S; Templeton L; Prater DA; Potter CJ
    J Parenter Sci Technol; 1989; 43(3):117-20. PubMed ID: 2732851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic variables and bioavailability from muscle of creatine kinase in cattle.
    Lefebvre HP; Toutain PL; Serthelon JP; Lassourd V; Gardey L; Braun JP
    Am J Vet Res; 1994 Apr; 55(4):487-93. PubMed ID: 8017694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tests for local toxicity of intramuscular drug preparations. Comparison of in vivo and in vitro findings.
    Surber C; Dubach UC
    Arzneimittelforschung; 1989 Dec; 39(12):1586-9. PubMed ID: 2624610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro model for assessing muscle irritation due to parenteral antibiotics.
    Williams PD; Masters BG; Evans LD; Laska DA; Hottendorf GH
    Fundam Appl Toxicol; 1987 Jul; 9(1):10-7. PubMed ID: 3622955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of particle size of parenteral suspensions on in vitro muscle damage.
    Brazeau G; Sauberan SL; Gatlin L; Wisniecki P; Shah J
    Pharm Dev Technol; 2011; 16(6):591-8. PubMed ID: 21214423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healing of muscle trauma after intramuscular injection of antibiotics in sheep: correlations between clinical, macroscopic and microscopic scores.
    Mikaelian I; Poul JM; Cabanié P
    Vet Res; 1996; 27(2):97-106. PubMed ID: 8721289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular injections and muscle damage: effects of concentration, volume, injection speed and vehicle.
    Svendsen O; Blom L
    Arch Toxicol Suppl; 1984; 7():472-5. PubMed ID: 6596017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat.
    Chellman GJ; Lollini LO; Dorr AE; DePass LR
    Hum Exp Toxicol; 1994 Feb; 13(2):111-7. PubMed ID: 7908807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in creatine kinase activity in serum following intramuscular injection].
    Surber C; Dubach UC; Forgò I
    Klin Wochenschr; 1988 Feb; 66(3):96-102. PubMed ID: 3352195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local toxicity of different drugs after intramuscular or intralipomatous injection in pigs: serum concentrations after three different formulations of cis(Z)-clopenthixol.
    Svendsen O; Blom L; Aaes-Jørgensen T; Larsen JJ
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):78-87. PubMed ID: 4061093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Creatine phosphokinase, myocardial infarction and intramuscular injection].
    Sauerwein HP; Brouwer T; Dunning AJ
    Ned Tijdschr Geneeskd; 1975 Sep; 119(37):1399-402. PubMed ID: 1178074
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro-in vivo myotoxicity of intramuscular liposomal formulations.
    al-Suwayeh SA; Tebbett IR; Wielbo D; Brazeau GA
    Pharm Res; 1996 Sep; 13(9):1384-8. PubMed ID: 8893279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of injection site damage and serum creatine kinase activity in turkeys following intramuscular and subcutaneous administration of norfloxacin nicotinate.
    Nyska A; Skolnick M; Ziv G; Gulkarov A
    Avian Pathol; 1994 Dec; 23(4):671-82. PubMed ID: 18671133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compared kinetics of plasma creatine kinase activity in rabbits after intravenous injection of different preparations of skeletal muscle.
    Lefebvre HP; Toutain PL; Bret L; Rico AG; Braun JP
    Vet Res; 1993; 24(6):468-76. PubMed ID: 8111429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.
    Brazeau GA; Fung HL
    Pharm Res; 1989 Sep; 6(9):766-71. PubMed ID: 2813273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic effects of the single intramuscular injection of ketamine, atropine and midazolam in a rat model.
    Barrueto F; Salleng K; Sahni R; Brewer KL
    Vet Hum Toxicol; 2002 Oct; 44(5):306-10. PubMed ID: 12361123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits.
    Escudero E; Fernández-Varón E; Marín P; Espuny A; Nájera MD; Cárceles CM
    Res Vet Sci; 2006 Dec; 81(3):366-72. PubMed ID: 16530237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled trial of topical nitroglycerin in a New Zealand white rabbit model of brown recluse spider envenomation.
    Lowry BP; Bradfield JF; Carroll RG; Brewer K; Meggs WJ
    Ann Emerg Med; 2001 Feb; 37(2):161-5. PubMed ID: 11174233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.